LEUCINE, N-[(2-FLUOROPHENYL)SULFONYL]-
- $350 - $1345
- Product name: LEUCINE, N-[(2-FLUOROPHENYL)SULFONYL]-
- CAS: 1041437-98-2
- MF: C12H16FNO4S
- MW: 289.3231432
- EINECS:
- MDL Number:MFCD03618988
- Synonyms:LEUCINE, N-[(2-FLUOROPHENYL)SULFONYL]-;N-[(2-FLUOROPHENYL)SULFONYL]LEUCINE;((2-Fluorophenyl)sulfonyl)leucine;((2-Fluorophenyl)sulfonyl)-L-leucine
5 prices
Selected condition:
Brand
- ACHEMBLOCK
- Matrix Scientific
Package
- 1G
- 2.500g
- 5G
- ManufacturerACHEMBLOCK
- Product numberL21068
- Product description((2-fluorophenyl)sulfonyl)leucine 95%
- Packaging1G
- Price$455
- Updated2021-12-16
- Buy
- ManufacturerACHEMBLOCK
- Product numberL21068
- Product description((2-fluorophenyl)sulfonyl)leucine 95%
- Packaging5G
- Price$1345
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number135989
- Product description((2-Fluorophenyl)sulfonyl)leucine 95%+
- Packaging1g
- Price$350
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number135989
- Product description((2-Fluorophenyl)sulfonyl)leucine 95%+
- Packaging2.500g
- Price$762
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number135989
- Product description((2-Fluorophenyl)sulfonyl)leucine 95%+
- Packaging5g
- Price$1154
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
ACHEMBLOCK | L21068 | ((2-fluorophenyl)sulfonyl)leucine 95% | 1G | $455 | 2021-12-16 | Buy |
ACHEMBLOCK | L21068 | ((2-fluorophenyl)sulfonyl)leucine 95% | 5G | $1345 | 2021-12-16 | Buy |
Matrix Scientific | 135989 | ((2-Fluorophenyl)sulfonyl)leucine 95%+ | 1g | $350 | 2021-12-16 | Buy |
Matrix Scientific | 135989 | ((2-Fluorophenyl)sulfonyl)leucine 95%+ | 2.500g | $762 | 2021-12-16 | Buy |
Matrix Scientific | 135989 | ((2-Fluorophenyl)sulfonyl)leucine 95%+ | 5g | $1154 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|